Solid Biosciences Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-43.2M | $-45.5M | $2.3M | $5.3M |
| FY2018 | $-70.2M | $-78.0M | $7.8M | $6.0M |
| FY2019 | $-92.7M | $-97.1M | $4.4M | $14.2M |
| FY2020 | $-56.6M | $-57.5M | $899.0K | $11.6M |
| FY2021 | $-77.8M | $-79.0M | $1.3M | $13.4M |
| FY2022 | $-98.0M | $-101.0M | $3.0M | $7.5M |
| FY2023 | $-94.2M | $-95.7M | $1.5M | $7.6M |
| FY2024 | $-100.0M | $-100.7M | $654.0K | $10.5M |
| FY2025 | $-156.3M | $-157.4M | $1.2M | $16.9M |